Hostname: page-component-77c89778f8-cnmwb Total loading time: 0 Render date: 2024-07-17T14:54:36.296Z Has data issue: false hasContentIssue false
  • English
  • Français

Direct Leukocyte Migration Inhibition In Multiple Sclerosis — A Possible Assessment of Activity

Published online by Cambridge University Press:  18 September 2015

M.P. Day ,
J.H. Day  and
P.L. Mann
M.P. Day*
Affiliation:
Division of Allergy and Clinical Immunology, Department of Medicine, Queen's University, Kingston, Canada
J.H. Day
Affiliation:
Division of Allergy and Clinical Immunology, Department of Medicine, Queen's University, Kingston, Canada
P.L. Mann
Affiliation:
Division of Allergy and Clinical Immunology, Department of Medicine, Queen's University, Kingston, Canada
*
Kingston General Hospital, Kingston, Ontario, Canada, K7L 2V7
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Twenty-four patients with multiple sclerosis were evaluated and classified according to their clinical state. Specific migration inhibition studies were carried out on blood samples from each using myelin basic protein, an acid soluble protein fraction isolated from normal human CNS white matter, and multiple sclerosis myelin basic protein isolated from patients who had the disease, as the antigenic material. This test system employed selected media. Results were compared with those of normal controls and patients with other neurological disease states. Antigen concentration of 500 μ glml in serum free medium combined to produce the greatest inhibiting effect on leukocytes in patients with apparent multiple sclerosis and differentiated these patients from those in the other groups tested.

Leukocytes in patients who had probable multiple sclerosis with partial impairment, signifying possible current activity of the disease, were especially inhibited as compared to the leukocytes from other groups tested against myelin antigen. Cerebrospinal fluid from affected patients when used as a media enhanced the test.

This study suggests that migration inhibition of peripheral leukocytes using myelin protein may be useful in the diagnosis of patients with multiple sclerosis. There is additional evidence that the degree of leukocyte migration inhibition may reflect activity of the disease with its consequent implications on treatment and prognosis.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 3 , Issue 2 , May 1976 , pp. 99 - 103
Copyright
Copyright © Canadian Neurological Sciences Federation 1976

References

REFERENCES

Bartfeld, H., and Atoynatan, T. (1970). In vitro delayed (cellular) hypersensitivity in multiple sclerosis to central nervous system antigens. International Archives of Allergy and Applied Immunology (Basel) 29, 361–367.CrossRefGoogle Scholar
Bartfeld, H., Atoynatan, T., and Donnenfeld, H. (1972). In vitro cellular immunity to central nervous system antigens in multiple sclerosis. Multiple Sclerosis: Immunology, Virology, and Ultrastructure. Edited by Wolfgram, F., Ellison, G.W., Stevens, J.S. and Andrews, J.M. Academic Press, 1972, 333–364.Google Scholar
Behan, P.O., Kies, M.W., Lisak, R.P., Sheremata, W. and Lamarche, J.B. (1973). Immunologic mechanisms in experimental encephalomyelitis in non human primates. Archives of Neurology. 29, 4–9.CrossRefGoogle Scholar
Bendixen, G., and Søborg, M. (1969). A leucocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man. Danish Medical Bulletin 16, 1–6.Google ScholarPubMed
Bendixen, G., and Soborg, M. (1970). Comments on the leucocyte migration technique as an in vitro method for demonstrating cellular hypersensitivity in man. Journal of Immunology 104, 1551–1552.CrossRefGoogle Scholar
Bergmann, L. Editor (1974). The international symposium on multiple sclerosis, Goteborg, 1972. Acta Neurologica Scandinavia 50, Supplement 58.Google Scholar
Brostoff, J. (1973. Leucocyte migration inhibition and its application. Allergologia et Immunopathologia, Supplementum I, 41–46.Google Scholar
Coulson, A. and Chalmers, D. (1964). Separation of viable lymphocytes from human blood. Lancet 1, 468–469.CrossRefGoogle ScholarPubMed
Day, E.D., and Wexler, M.A. (1974). The antibody response to myelin basic pro-tein in Lewis and Fischer rats as followed by a sodium sulfate method of radioim-munoassay. Journal of Immunology 113, 1952–1957.CrossRefGoogle Scholar
Falk, R.E., Mann, P., and Langer, B. (1973). Cell-mediated immunity to human tumours. Archives of Surgery 107, 261–265.CrossRefGoogle Scholar
Gagnon, J., Finch, P.R., Wood, D.D., and Moscarello, M.A. (1971). Isolation of a highly purified myelin protein. Biochemistry 10, 4756–4763.CrossRefGoogle ScholarPubMed
Gilland, O. (1965). Multiple sclerosis classification scheme integrating clinical and CSF findings. Acta Neurologica Scandinavica 41, Supplement13, part II, 563–575.CrossRefGoogle Scholar
McAlpine, D., Lumsden, C, andAcheson, E.D. (1972). Multiple sclerosis — a reappraisal. Churchill Livingstone Publishers.Google Scholar
McDermott, J.R., Field, E.J., and Caspary, E.A. (1974). Relation of measles virus to encephalitogenic factor with reference to the aetiopathogenesis of multiple sclerosis. Journal of Neurology. Neurosurgery and Psychiatry 27, 282–287.CrossRefGoogle Scholar
Morley, J. (1974). Cell migration inhibition: an appraisal. Acta Allergologica 29, 185–208.CrossRefGoogle ScholarPubMed
Myers, L.W. (1972). Leucocyte migration inhibition in multiple sclerosis from Multi-ple Sclerosis: Immunology, Virology, and Ultrastructure. Edited by Wolfgram, F., Ellison, G.W., Stevens, J.A. , and Andrews, J.M., New York. Academic Press 1972, 383–402.Google Scholar
Myers, L.W., and Ellison, G.W. (1973). Effect of humoral factors on cellular hypersensitivity to nervous tissue in Multiple Sclerosis. Federation Proceedings 32, 832.Google Scholar
Offner, H., Ammitzboll, T., Clausen, J.. Fog, T., Hyllested, K. and Einstein, E. (1974). Immune response of lymphocytes from patients with multiple sclerosis to phytohemagglutinin, basic protein of myelin and measles antigens. Acta Neurologica Scandinavica 50, 373–381.CrossRefGoogle ScholarPubMed
Olsson, J., and Link, H. (1973). Immunoglobulin abnormalities in multiple sclerosis. Archives or Neurology 28. 392–399.CrossRefGoogle ScholarPubMed
Paty, D.W.. Mervart, H., Campling, B.. Rand, C.G., and Stiller, C.R. (1974). HL-A frequencies in patients with multiple sclerosis. The Canadian Journal of Neurological Sciences 1, 211–213.CrossRefGoogle ScholarPubMed
Rocklin, R.E. (1974). Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (M1F). Journal of Immunology 112, 1461–1466.CrossRefGoogle Scholar
Rocklin, R.E., Sheremata, W.A.. Feldman, R.G.. Kies, M.W. and David, J.R. (1971). The Guillain-Barre Syndrome and multiple sclerosis. New England Journal of Medicine 284, 803–808.CrossRefGoogle ScholarPubMed
Rose, A.S. (1974). Multiple Sclerosis, a clinical and theoretical review. Journal of Neurosurgery 41, 279–284.CrossRefGoogle ScholarPubMed
Salmi, A., Panelius, M., and Vainionpāā, R. (1974). Antibodies against different viral antigens in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Acta Neurologica Scandinavica 50, 183–193.CrossRefGoogle ScholarPubMed
Sheremata, W., Cosgrove, J.B.R., and Eylar, E.H. (1974). Cellular hyper-sensitivity to basic myelin (A1) protein and clinical multiple sclerosis. New England Journal of Medicine 291, 14–17.CrossRefGoogle Scholar
Strangaard, S. and Jorgensen, P. (1972). Delayed hypersensitivity to myelin antigen in multiple sclerosis investigated with the leucocyte migration method. Acta Neurologica Scandinavica 48, 243–248.CrossRefGoogle Scholar